<div>
  <ul>
    <li>
      <p>
        Exact Sciences has partnered with Mayo Clinic to offer patients genomic profiling and hereditary cancer tests. This venture will widen the scope of data that Mayo Clinic researchers and clinicians can use for cancer research and patient care.
      </p>
    </li>
    <li>
      <p>
        The collaboration leverages the OncoExTra and Riskguard tests from Exact Sciences. This is expected to aid in personalized treatment planning and support the development of new diagnostic tests and cancer therapies. The collected data would further be integrated into AI algorithms to predict cancer risk, early detection, and guide intervention.
      </p>
    </li>
    <li>
      <p>
        The Mayo Clinic is a non-profit American academic medical center dedicated to integrated healthcare, education, and research.&nbsp;
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.exactsciences.com/newsroom/press-releases/exact-sciences-to-provide-mayo-clinic-patients-with-individualized-cancer-tumor-information">
      Press release
    </a>
  </p>
</div>


Precision Medicine

INCUMBENTS_PRESENT

PROMINENT_CATEGORY

<div>
 <p>Exact Sciences and Mayo Clinic have formed a partnership to provide patients with genomic profiling and hereditary cancer tests. This collaboration aims to expand the data available to Mayo Clinic's researchers and clinicians for cancer research and patient care.</p>
 <p>The partnership will utilize the OncoExTra and Riskguard tests from Exact Sciences, assisting in personalized treatment planning and facilitating the creation of new diagnostic tests and cancer treatments. The acquired data will also be incorporated into AI algorithms to forecast cancer risk, detect it early, and direct intervention strategies.</p>
 <p>Mayo Clinic is an American non-profit academic medical center devoted to combined healthcare, education, and research.&nbsp;</p>
</div>

Exact Sciences partners with Mayo Clinic to provide genomic profiling and hereditary cancer tests to Mayo Clinic patients

Technologies bringing about a new reality

Extended Reality

ANALYST_QUICK_TAKE

<div>
 <p>ApoQlar, a medical visualization platform, is entering a partnership with Mayo Clinic to incorporate its Extended Reality (XR) technology into patient care planning facilities. This collaboration aims to merge the technological capabilities of apoQlar with the vast medical expertise of Mayo Clinic.</p>
 <p>The objective is to develop personalized treatment plans for cancer patients by creating 3D visuals of medical data. This advancement is anticipated to enhance treatment precision, leading to improved patient outcomes and increased satisfaction. The collaboration will commence with a specific project at Mayo Clinic, which aims to create 3D interactive virtual platforms. This project will aid specialists in formulating optimal treatment plans for patients.&nbsp;</p>
</div> <p><b>Analyst QuickTake:<br>
 </b> This news highlights using apoQlar’s funds raised in <a href="https:<br>
//sp-edge.com/updates/19877"> July 2023 </a> to collaborate with healthcare providers and surgical teams to improve patient outcomes and surgical practices. Additionally, the partnership adds to apoQlar’s 60+ list of medical institution partners.</p>

apoQlar partners with Mayo Clinic to improve patient care utilizing XR

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div>
 
 <p>Telemedicine provider K Health is collaborating with Mayo Clinic to create an AI solution for preventing premature deaths from heart disease and stroke. Using K Health's proprietary algorithms, they will develop an advanced AI-ECG technology leveraging de-identified patient data from Mayo Clinic. The AI model will consider patient-specific factors like age, gender, and health history for optimized treatment and risk prediction. The project, set to begin in early 2024, will be overseen by Mayo Clinic cardiologists Francisco Lopez-Jimenez and Amir Lerman.</p>
 
</div>

K Health partners with Mayo Clinic to develop AI solution for heart disease prevention

Artificial intelligence is identifying and testing new therapies faster than ever.

AI Drug Discovery

<div>
 <p>AI drug discovery company SimBioSys and Mayo Clinic are partnering to develop cloud-based software for breast cancer patients. The software will assist with decision-making for early-stage patients, including personalized treatment plans. SimBioSys is also creating TumorSight, a cloud-based platform currently under FDA review, that uses patient imaging to develop a 3D model for surgical planning. The Illinois-based company, established in 2016, specializes in precision medicine for cancer care, using a platform that simulates interactions within a patient’s tumor to identify optimal treatments.</p>
</div>

SimBioSys and Mayo Clinic collaborate to develop solutions for breast cancer

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

<div>
 <p>Chronic care management company Ayble Health has partnered with health system Mayo Clinic to offer a hybrid care model for patients with chronic gastrointestinal (GI) conditions. This model combines virtual and in-person care options and can be accessed through employers and health plans.</p>
 <p>Ayble Health utilizes AI-guided personalization and expert health coaching to address each patient's unique needs. Patients who qualify for in-person care will receive initial treatment at the Mayo Clinic, followed by ongoing support from Ayble for nutritional and behavioral assistance in their local community.</p>
</div> <p><b>Analyst QuickTake: </b> This partnership follows Ayble Health’s recent D2C app launch in <a href="https://www.fiercehealthcare.com/digital-health/ayble-health-mayo-clinic-collaborate-treat-high-acuity-patients"> April 2023 </a> , where the company expressed its aim for clinician endorsement and integration of the app with existing treatment plans. The company plans to distinguish itself from competitors, such as <a href="https://sp-edge.com/companies/718164"> Oshi Health </a> and <a href="https://sp-edge.com/companies/672307"> Vivante Health </a> , through its unique coach-first model via strategic partnerships enabling cost-effective, personalized care at scale.</p>

Ayble Health partners with Mayo Clinic to enhance care of chronic GI patients

Naveris partners with Mayo Clinic to launch Dart 2.0 clinical trial

Healium raises USD 3.6 million in oversubscribed seed funding, partners with Mayo Clinic

A new industry proving that digital connectivity and mental health can co-exist.

All Updates

Exact Sciences partners with Mayo Clinic to provide genomic profiling and hereditary cancer tests to Mayo Clinic patients

apoQlar partners with Mayo Clinic to improve patient care utilizing XR

K Health partners with Mayo Clinic to develop AI solution for heart disease prevention

SimBioSys and Mayo Clinic collaborate to develop solutions for breast cancer

Ayble Health partners with Mayo Clinic to enhance care of chronic GI patients

Naveris partners with Mayo Clinic to launch Dart 2.0 clinical trial

Healium raises USD 3.6 million in oversubscribed seed funding, partners with Mayo Clinic

Healium raises USD 3.6 million in oversubscribed seed funding, partners with Mayo Clinic

Ultromics receives FDA approval for EchoGo Heart Failure solution

Precision Medicine

Exact Sciences partners with Mayo Clinic to provide genomic profiling and hereditary cancer tests to Mayo Clinic patients

Contact us